Obserwuj
Andrzej Stepulak
Andrzej Stepulak
Head of the Dept. of Biochemistry and Molecular Biology, Medical University in Lublin, Poland
Zweryfikowany adres z umlub.pl
Tytuł
Cytowane przez
Cytowane przez
Rok
Comprehensive review on betulin as a potent anticancer agent
SK Król, M Kiełbus, A Rivero-Müller, A Stepulak
BioMed research international 2015, 2015
2392015
Expression of glutamate receptor subunits in human cancers
A Stepulak, H Luksch, C Gebhardt, O Uckermann, J Marzahn, M Sifringer, ...
Histochemistry and cell biology 132, 435-445, 2009
2242009
Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain
HH Hansen, T Briem, M Dzietko, M Sifringer, A Voss, W Rzeski, ...
Neurobiology of disease 16 (2), 440-453, 2004
2072004
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth
A Stepulak, M Sifringer, W Rzeski, S Endesfelder, A Gratopp, EE Pohl, ...
Proceedings of the National Academy of Sciences 102 (43), 15605-15610, 2005
1732005
Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells
W Rzeski, A Stepulak, M Szymański, M Sifringer, J Kaczor, K Wejksza, ...
Naunyn-Schmiedeberg's archives of pharmacology 374, 11-20, 2006
1722006
Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity
N Tanaka, S Kanatani, R Tomer, C Sahlgren, P Kronqvist, D Kaczynska, ...
Nature Biomedical Engineering 1 (10), 796-806, 2017
1642017
Glutamate and its receptors in cancer
A Stepulak, R Rola, K Polberg, C Ikonomidou
Journal of neural transmission 121, 933-944, 2014
1642014
The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase
T He, A Stepulak, TH Holmström, MB Omary, JE Eriksson
Journal of Biological Chemistry 277 (13), 10767-10774, 2002
1522002
Glutamate receptors in pediatric tumors of the central nervous system
KS Brocke, C Staufner, H Luksch, KD Geiger, A Stepulak, J Marzahn, ...
Cancer biology & therapy 9 (6), 455-468, 2010
1312010
Silencing of selected glutamate receptor subunits modulates cancer growth
H Luksch, O Uckermann, A Stepulak, S Hendruschk, J Marzahn, ...
Anticancer research 31 (10), 3181-3192, 2011
1082011
MicroRNAs-role in lung cancer
M Guz, A Rivero-Müller, E Okoń, A Stenzel-Bembenek, K Polberg, ...
Disease markers 2014, 2014
932014
Betulin Elicits Anti‐Cancer Effects in Tumour Primary Cultures and Cell Lines In Vitro
W Rzeski, A Stepulak, M Szymański, M Juszczak, A Grabarska, ...
Basic & clinical pharmacology & toxicology 105 (6), 425-432, 2009
932009
Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells
A Stepulak, W Rzeski, M Sifringer, K Brocke, A Gratopp, K Kupisz, L Turski, ...
Cancer biology & therapy 7 (10), 1685-1693, 2008
922008
Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood
A Szuster-Ciesielska, E Hryciuk-Umer, A Stepulak, K Kupisz, ...
Acta oncologica 43 (3), 252-258, 2004
912004
Histone deacetylase inhibitors and phenotypical transformation of cancer cells
A Wawruszak, J Kalafut, E Okon, J Czapinski, M Halasa, ...
Cancers 11 (2), 148, 2019
842019
The role of matrix metalloproteinases in infant traumatic brain injury
M Sifringer, V Stefovska, I Zentner, B Hansen, A Stepulak, C Knaute, ...
Neurobiology of disease 25 (3), 526-535, 2007
732007
Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines–An isobolographic analysis
A Wawruszak, JJ Luszczki, A Grabarska, E Gumbarewicz, ...
PLoS One 10 (11), e0143013, 2015
682015
H3K18Ac as a marker of cancer progression and potential target of anti-cancer therapy
M Hałasa, A Wawruszak, A Przybyszewska, A Jaruga, M Guz, J Kałafut, ...
Cells 8 (5), 485, 2019
572019
7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro
M KIEŁBUS, K SKALICKA-WOŹNIAK, A Grabarska, W Jeleniewicz, ...
Anticancer research 33 (10), 4347-4356, 2013
542013
Histone deacetylase inhibitor SAHA as potential targeted therapy agent for larynx cancer cells
A Grabarska, JJ Łuszczki, E Nowosadzka, E Gumbarewicz, W Jeleniewicz, ...
Journal of Cancer 8 (1), 19, 2017
512017
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20